RecruitingPhase 3NCT05980949Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb companyCypress, TX · DeSoto, TX · El Paso, TX · +145 more sites
RecruitingPhase 2NCT06808984Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's DiseaseSponsor: CelgeneAustin, TX · Cypress, TX · El Paso, TX · +57 more sites
RecruitingPhase 3NCT06585787A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb companyAustin, TX · Dallas, TX · DeSoto, TX · +99 more sites